The most common side effects of Rybelsus are gastrointestinal, including nausea, diarrhoea, vomiting, abdominal discomfort, and decreased appetite
It reduces systemic inflammation, which may make some patients feel less bloated, but this is not the same as losing body fat
More receptor activation in the stomach and intestines means slower stomach emptying, which is already the primary mechanism of action
The most common include mild to moderate nausea, vomiting, diarrhea, and stomach discomfort
Ways to reduce costs: Manufacturer savings programs from Novo Nordisk Coupons and discounts Patient assistance programs FSA/HSA funds (weight loss medications may be eligible) Compounded semaglutide options (typically more affordable) Better coverage is often available when semaglutide is prescribed for type 2 diabetes compared to weight loss alone
These trials were on people with type 2 diabetes